Innovation versus Financialization in the US Pharmaceutical Industry (Paperback)

Language: English

Published by Cambridge University Press, Cambridge, 2025

1009707981 / 9781009707985

  • Softcover
  • New
See all details

Seller: CitiRetail, Stevenage, United KingdomCitiRetail

5-star seller

AbeBooks seller since June 29, 2022

Softcover

Condition: New

£ 23.49

£ 37.00 shipping 
Ships from United Kingdom to U.S.A.

Quantity: 1 available

Add to basket
Free 30-day returns

Item description from seller

Paperback. Mandated by the Inflation Reduction Act of 2022, the US government is negotiating with pharmaceutical companies over the 'maximum fair price' of ten drugs widely used by Medicare patients. The pharmaceutical companies contend that a 'fair' price is a 'value-based price' that enables their shareholders to capture the value the drug creates for society and warn that lowering drug prices will reduce investments in new drugs. This Element responds to these arguments by showing that pharmaceutical companies (a) should have their drug prices regulated, given scale economies in supplying drugs and price inelasticity of drug demand; (b) use their profits from unregulated drug prices to distribute cash dividends and stock buybacks to shareholders; (c) do not typically rely upon investment by shareholders to fund drug innovation; and (d) benefit from 'collective and cumulative learning' in foundational and translational research that is antecedent and external to their investments in clinical research. The US government is negotiating with pharmaceutical companies on the price of ten drugs. This Element shows that the companies (a) should have their drug prices regulated, (b) use their profits to distribute cash dividends and stock buybacks; (c) do not rely on investment by shareholders; and (d) benefit from 'collective and cumulative learning.' Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.…

Seller Inventory # 9781009707985

Title
Innovation versus Financialization in the US Pharmaceutical Industry (Paperback)
Author
OEner Tulum
Publisher
Cambridge University Press, Cambridge
Publication year
2025
Condition
new
Binding
Paperback
Language
English
ISBN 10
1009707981
ISBN 13
9781009707985

CitiRetail

Stevenage, United Kingdom

5-star seller

AbeBooks seller since June 29, 2022

Shipping rates from United Kingdom to U.S.A.

Item7 to 14 business days7 to 60 business days
First item£ 37.00£ 37.00
Delivery times are set by sellers and vary by carrier and location. Orders passing through Customs may face delays and buyers are responsible for any associated duties or fees. Sellers may contact you regarding additional charges to cover any increased costs to ship your items.

Payment methods

  • Visa
  • Mastercard
  • American Express
  • Apple Pay
  • Google Pay

Store description

Online business

Seller's business information

ABC BOOKS LIMITED

10 John Street
London, United Kingdom WC1N 2EB